| Using Red Light Therapy to Ease Skin Side Effects and Mouth Side Effects, in Children and Young People Aged 0 to 16 Years Old, Receiving Radiotherapy (NCT07183267) | The Christie NHS Foundation Trust | 2026-06-01 |
| Investigation of the ROle of faT and inflAmmaTory Cells in mElanoma (NCT07293598) | The Christie NHS Foundation Trust | 2026-01-01 |
| A Phase III Randomised Control Clinical Trial of Radiotherapy With Radiosensitisation Versus Intravesical Bacillus Calmette-Guerin Therapy for High-risk Non-muscle Invasive Bladder Cancer. (NCT07268339) | The Christie NHS Foundation Trust | 2025-12-01 |
| To Determine Whether it is Feasible to Treat Patients Requiring Urgent Radiotherapy Diagnosed With Metastatic Cord Compression (MSCC) on the Magnetic Resonance Linear Accelerator (MRL) in a Single Appointment and Compare it to the Standard of Care Radiotherapy Pathway (NCT06965101) | The Christie NHS Foundation Trust | 2025-11-04 |
| A Feasibility Study of MRI Guided Stereotactic Ablative Radiotherapy (MIDSECTION) (NCT05903430) | The Christie NHS Foundation Trust | 2025-08-29 |
| Pragmatic Analysis of Complex Radiotherapy Cases In Cancer of the Lung (NCT07202260) | The Christie NHS Foundation Trust | 2025-07-03 |
| Pencil Beam Scanning Proton Beam Radiotherapy for the Management of Abdominal Neuroblastoma (NCT06804447) | The Christie NHS Foundation Trust | 2025-03-01 |
| Preoperative Preradiotherapy TTFields (NCT06136611) | The Christie NHS Foundation Trust | 2024-12-19 |
| Chronic Radiation Induced Bowel Toxicity Study (NCT06640959) | The Christie NHS Foundation Trust | 2024-11-19 |
| Investigating the Role of Adjuvant Proton Beam Therapy in Patients With Parotid Carcinoma (NCT06421649) | The Christie NHS Foundation Trust | 2024-11-01 |
| Evaluation of Combined Modality Protons and Hepatic Transplantation for Hilar Cholangiocarcinoma (NCT06434493) | The Christie NHS Foundation Trust | 2024-11-01 |
| Exploratory Study of EBV DNA Titre Clearance Whilst on Proton Beam Therapy (NCT06480903) | The Christie NHS Foundation Trust | 2024-08-30 |
| Enabling Genomic Testing in Cancer of Unknown Primary (NCT06695494) | The Christie NHS Foundation Trust | 2024-08-15 |
| Circulating Tumour DNA Guided Adaptive BRAF and MEK Inhibitor Therapy (NCT06470880) | The Christie NHS Foundation Trust | 2024-06-01 |
| PatIent exPeRiences and prEFerence of trEatment foR Multiple Myeloma (NCT06322927) | The Christie NHS Foundation Trust | 2024-04-05 |
| The CASCADE Project (NCT06117592) | The Christie NHS Foundation Trust | 2024-03-01 |
| Molecular Characterisation of Appendiceal Cancer (NCT05364788) | The Christie NHS Foundation Trust | 2024-02-04 |
| Molecular Characterisation of Colorectal Cancer Peritoneal Metastases (NCT05513716) | The Christie NHS Foundation Trust | 2024-02-04 |
| A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer (NCT04188119) | The Christie NHS Foundation Trust | 2023-12-01 |
| Assessing the Relationship Between Hypoxia and the Immune Environment in Myeloma Patients (CHIME) (NCT06007989) | The Christie NHS Foundation Trust | 2023-11-01 |
| Introduction of Y90-PET-CT Post Radioembolisation Therapy Scans (NCT06123676) | The Christie NHS Foundation Trust | 2023-10-09 |
| Radial Artery Access (NCT05768412) | The Christie NHS Foundation Trust | 2023-05-04 |
| Musculoskeletal Health in Adult Haematological Cancer Survivors (NCT05865678) | The Christie NHS Foundation Trust | 2023-05-02 |
| The Use and Development of Patient Reported Outcome Measures (PROMs) in the Adoptive Cell Therapy (ACT) Setting (NCT05721365) | The Christie NHS Foundation Trust | 2023-03-28 |
| Feasibility of Utilising Brushing Cytology and Dermoscopy for Diagnosing Penile Lesions (NCT05662839) | The Christie NHS Foundation Trust | 2023-01-01 |
| PreOperative Brain Irradiation in Glioblastoma (NCT03582514) | The Christie NHS Foundation Trust | 2022-04-19 |
| Development of a Patient Reported Outcome Measure for Advanced Ovarian Cancer Patients Receiving Surgical and Chemotherapy Treatment (NCT05274867) | The Christie NHS Foundation Trust | 2022-03-07 |
| Remote Monitoring of Patients at Risk of Sepsis (NCT04260230) | The Christie NHS Foundation Trust | 2022-03-01 |
| NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts (NCT04960059) | The Christie NHS Foundation Trust | 2022-02-11 |
| Upper GI Serial Tumour Biopsies (NCT05233007) | The Christie NHS Foundation Trust | 2022-01-25 |
| Circulating Tumour DNA guidEd Therapy for Stage IIB/C mElanoma After surgiCal resecTION (NCT04901988) | The Christie NHS Foundation Trust | 2021-11-08 |
| Hypoxia-driven Prostate Cancer Genomics (HYPROGEN) (NCT05702619) | The Christie NHS Foundation Trust | 2021-10-03 |
| MRI Development for Radiotherapy Planning and Delivery in Non-Patient Volunteers (NCT04749134) | The Christie NHS Foundation Trust | 2021-08-01 |
| Lung Screening in People Cured of Hodgkin Lymphoma (NCT04986189) | The Christie NHS Foundation Trust | 2021-08-01 |
| Anorexia iN Cancer Patients: ANCHOR (NCT04791254) | The Christie NHS Foundation Trust | 2021-07-15 |
| Effect of Pelvic Radiotherapy on the Intestinal Microbiome and Metabolome (NCT04995809) | The Christie NHS Foundation Trust | 2021-07-05 |
| Tumour Characterisation to Guide Experimental Targeted Therapy - National (NCT04723316) | The Christie NHS Foundation Trust | 2021-06-30 |
| Carcinoma of Unknown Primary (CUP): a Comparison Across Tissue and Liquid Biomarkers (NCT04750109) | The Christie NHS Foundation Trust | 2021-06-09 |
| A Survey Exploring Health and Screening Tests in People Treated for Hodgkin Lymphoma (NCT04996862) | The Christie NHS Foundation Trust | 2021-06-01 |
| Quantification of Abdominal Organ Motion Using MRI (NCT04748094) | The Christie NHS Foundation Trust | 2021-05-21 |
| COvid-19 aNd TechNology - thE Impact on Clinical Trial Patients (NCT04852809) | The Christie NHS Foundation Trust | 2021-05-18 |
| Bone Toxicity Following Pelvic Radiotherapy (NCT04555317) | The Christie NHS Foundation Trust | 2021-05-17 |
| Qualitative Exploration of Head & Neck Cancer Patient Reported Experience of Radiotherapy (NCT04543045) | The Christie NHS Foundation Trust | 2021-05-05 |
| The CAPER Trial: A Phase Ib Clinical Trial of Cyclophosphamide And PEmbrolizumab in Metastatic Renal Cell Carcinoma (NCT04262427) | The Christie NHS Foundation Trust | 2021-04-28 |
| The Psychological Impact of COVID-19 on Patients with Solid Malignancies: a Single-Institution Survey Study (NCT05359718) | The Christie NHS Foundation Trust | 2021-03-01 |
| Impact on Quality of Life From Multi-modality Lung Cancer (NCT04540757) | The Christie NHS Foundation Trust | 2020-11-25 |
| Impact of COVID-19 on Lung Cancer Patients (NCT04538456) | The Christie NHS Foundation Trust | 2020-10-15 |
| Remote Monitoring of Cancer Patients With Suspected Covid-19 (NCT04397705) | The Christie NHS Foundation Trust | 2020-10-12 |
| COntinuous Signs Monitoring In Covid-19 Patients (NCT04581031) | The Christie NHS Foundation Trust | 2020-07-11 |
| Developing Lung Cancer Screening in Hodgkin Lymphoma Survivors: a Qualitative Study (NCT04396119) | The Christie NHS Foundation Trust | 2020-02-11 |
| A Proof of Concept, Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer (NCT03794596) | The Christie NHS Foundation Trust | 2019-09-01 |
| PDAC Peripheral and Portal Vein Sampling (NCT04289961) | The Christie NHS Foundation Trust | 2019-06-12 |
| The Goals of Care Initiative (NCT04020679) | The Christie NHS Foundation Trust | 2019-06-11 |
| Personalised Disease Monitoring in Metastatic Breast Cancer (NCT04597580) | The Christie NHS Foundation Trust | 2019-05-08 |
| CAcTUS - Circulating Tumour DNA Guided Switch (NCT03808441) | The Christie NHS Foundation Trust | 2019-05-02 |
| A Translational Study Investigating PD-L1 Expression After Radiotherapy for Non-small Cell Lung Cancer (NCT03258788) | The Christie NHS Foundation Trust | 2019-01-03 |
| Irinotecan Drug-eluting Bead Liver Embolisation Registry (NCT03697044) | The Christie NHS Foundation Trust | 2019-01-01 |
| Serial Tumour Biopsies and Blood Biomarkers in Melanoma (NCT04493723) | The Christie NHS Foundation Trust | 2018-11-14 |
| Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine Carcinoma (NCT03837977) | The Christie NHS Foundation Trust | 2018-11-13 |
| Development and Validation of a Patient Reported Experience Measure for Experimental Cancer Medicine (NCT05386602) | The Christie NHS Foundation Trust | 2018-07-16 |
| Pancreatic Cancer Dietary Assessment Study (NCT03616431) | The Christie NHS Foundation Trust | 2018-07-03 |
| Patient Experience of Consent for Cancer Surgery in Light of Recent Changes to UK Law- a Questionnaire Study (NCT04024189) | The Christie NHS Foundation Trust | 2018-04-01 |
| A Study Using MRI To Assess Bladder Motion During Radiotherapy (NCT03409029) | The Christie NHS Foundation Trust | 2018-03-01 |
| Magnetic Resonance Imaging (MRI) for the Delineation of Organs At Risk (OAR) and Target Volumes in Lung Cancer Patients (NCT03048760) | The Christie NHS Foundation Trust | 2017-09-11 |
| A Pilot Study Using Magnetic Resonance (MR) to Assess Cervix Motion During Radiotherapy Treatment. (NCT03101306) | The Christie NHS Foundation Trust | 2017-09-01 |
| Multi-maintenance Olaparib After Disease Recurrence in Participants With Platinum Sensitive BRCAm High Grade Serous Ovarian Cancer (NCT02855697) | The Christie NHS Foundation Trust | 2017-05-26 |
| Respiratory Distress Symptom Intervention (RDSI) Trial (NCT03223805) | The Christie NHS Foundation Trust | 2017-04-04 |
| ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancers (NCT02351765) | The Christie NHS Foundation Trust | 2016-01-01 |
| PLX3397 KIT in Acral aNd mucOsal Melanoma (NCT02071940) | The Christie NHS Foundation Trust | 2015-10-01 |
| A Study to Evaluate a Diary for Patient Reported Outcome Measures (PROMs) (NCT02507804) | The Christie NHS Foundation Trust | 2015-07-01 |
| Standard Care Alone or With Acupuncture for CIPN in Breast Cancer and Multiple Myeloma (NCT02275403) | The Christie NHS Foundation Trust | 2015-04-13 |
| Study to Determine the Feasibility, Evaluability and Variability in Markers of Drug Action in Castration Resistant Prostate Cancer (NCT02424448) | The Christie NHS Foundation Trust | 2014-12-01 |
| NIMRAD (A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab) (NCT01950689) | The Christie NHS Foundation Trust | 2014-09-11 |
| PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian Cancer (NCT02055690) | The Christie NHS Foundation Trust | 2014-09-01 |
| Study to Determine the Feasibility of Sentinel Node Biopsy in Patients With Anal Cancer (NCT02162641) | The Christie NHS Foundation Trust | 2014-09-01 |
| TIL Therapy in Metastatic Melanoma and IL2 Dose Assessment (NCT01995344) | The Christie NHS Foundation Trust | 2014-03-01 |
| Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers (NCT01926236) | The Christie NHS Foundation Trust | 2014-02-01 |
| MRI in Pre-operative Radiotherapy for Soft Tissue Sarcoma: MISTS Study (NCT01956019) | The Christie NHS Foundation Trust | 2014-02-01 |
| Development of a Biomarker Directed Strategy to Ameliorate Common Toxicities From Conventional Chemotherapy (NCT01921998) | The Christie NHS Foundation Trust | 2013-10-01 |
| The Use of Rectal Balloons in Radical Pelvic Radiotherapy - a Feasibility Study (NCT01842750) | The Christie NHS Foundation Trust | 2013-08-01 |
| Radiotherapy & Olaparib in COmbination for Carcinoma of the Oesophagus (NCT01460888) | The Christie NHS Foundation Trust | 2013-07-01 |
| Measurement of Gemcitabine Metabolites in Blood and Urine as Predictors of Response to GemX Bladder Radiotherapy (NCT01343121) | The Christie NHS Foundation Trust | 2012-02-02 |
| Dual REctcal Angiogenesis or MEK Inhibition radioTHERAPY Trial (NCT01160926) | The Christie NHS Foundation Trust | 2010-07-01 |
| MEK Inhibitor and Thoracic Radiotherapy Trial (NCT01146756) | The Christie NHS Foundation Trust | 2010-06-04 |
| RESPeCT: Revlimid Early Stage Poor Prognosis Chronic Lymphocytic Leukaemia (CLL) Trial (NCT01127542) | The Christie NHS Foundation Trust | 2010-05-01 |
| Window Study of ZD4054 in Metastatic Prostate Cancer (NCT01168141) | The Christie NHS Foundation Trust | 2009-07-01 |
| Erbitux Study of CPT11, Oxaliplatin, UFToral Targeted Therapy (NCT01225744) | The Christie NHS Foundation Trust | 2009-04-01 |
| Concurrent Once Daily Versus Twice Daily Radiotherapy for Limited Stage Small Cell Lung Cancer (NCT00433563) | The Christie NHS Foundation Trust | 2008-04-01 |
| A Phase I Study of CD19 Specific T Cells in CD19 Positive Malignancy (NCT01493453) | The Christie NHS Foundation Trust | 2008-03-01 |
| Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX (NCT00900211) | The Christie NHS Foundation Trust | 2007-08-01 |
| Phase II Study of Fractionated 90Y Ibritumomab Tiuxetan (Zevalin) Radioimmunotherapy as an Initial Therapy of Follicular Lymphoma (NCT01493479) | The Christie NHS Foundation Trust | 2007-06-06 |
| Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery (NCT00599833) | The Christie NHS Foundation Trust | 2007-05-01 |
| Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer (NCT00601406) | The Christie NHS Foundation Trust | 2006-03-01 |
| Effect of Pegvisomant on GH/IGF-I Relationship in GHD (NCT00468624) | The Christie NHS Foundation Trust | 2004-12-01 |
| Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or Carboplatin (NCT00055965) | The Christie NHS Foundation Trust | 2002-11-01 |
| Gemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NCT00022009) | The Christie NHS Foundation Trust | 2001-07-01 |
| Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer (NCT00005038) | The Christie NHS Foundation Trust | 1999-06-01 |
| Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery (NCT00004887) | The Christie NHS Foundation Trust | 1999-01-01 |
| Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin (NCT00022178) | The Christie NHS Foundation Trust | 1998-12-01 |
| Temozolomide in Treating Women With Advanced Breast Cancer (NCT00005054) | The Christie NHS Foundation Trust | 1998-05-01 |